Evidence map›Paper›PMID 41150687›Full record

ArticlePloS one2025

Enhanced local feature extraction of lite network with scale-invariant CNN for precise segmentation of small brain tumors in MRI.

Wei Yuan, Han Kang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei YuanCollege of Computer Science, Chengdu University, Chengdu, China.
Han KangPrenatal diagnosis department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.ORCID https://orcid.org/0000-0003-4851-6412

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning has emerged as the preeminent technique for semantic segmentation of brain MRI tumors. However, existing methods often rely on hierarchical downsampling to generate multi-scale feature maps, effectively capturing fine-grained global features but struggling with large-scale local features due to insufficient network depth. This limitation is particularly detrimental for segmenting diminutive targets such as brain tumors, where local feature extraction is crucial. Augmenting network depth to address this issue leads to excessive parameter counts, incompatible with resource-constrained devices. To tackle this challenge, we propose that object recognition should exhibit scale invariance, so we introduce a shared CNN network architecture for image encoding. The input MRI image is directly downsampled into three scales, with a shared 10-layer convolutional network employed across all scales to extract features. This approach enhances the network's ability to capture large-scale local features without increasing the total parameter count. Further, we utilize a Transformer on the smallest scale to extract global features. The decoding stage follows the UNet structure, incorporating incremental upsampling and feature fusion from previous scales. Comparative experiments on the LGG Segmentation Dataset and BraTS21 dataset demonstrate that our proposed LiteMRINet achieves higher segmentation accuracy while significantly reducing parameter count. This makes our approach particularly advantageous for devices with limited memory resources. Our code is available at https://github.com/chinaericy/MRINet.

Indexed as

Brain NeoplasmsImage Processing, Computer-AssistedMagnetic Resonance ImagingNeural Networks, ComputerAlgorithmsDeep LearningHumans

Identifiers

PMID41150687
PMCPMC12561956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.